BioLizard’s AI expertise highlighted in European Biotechnology
BioLizard CEO Liesbeth Ceelen shares her insights on AI in life sciences in European Biotechnology. The article explores how AI and machine learning can accelerate research and innovation, while addressing concerns around job impact and broader societal implications.
“Depending on who you talk to, artificial intelligence (AI) is either a saviour or an enslaver. The concerns range from loss of jobs through to robots running society. However, in the life sciences, the use of AI and machine learning (ML) have created some excitement over their potential applications.”
Our CEO Liesbeth Ceelen shares her expertise in an article recently published in European Biotechnology.
Read the whole article here.